How to manage warfarin therapy

Philip A. Tideman; Rosy Tirimacco; Andrew St. John; Gregory W. Roberts

doi:10.18773/austprescr.2015.016

How to manage warfarin therapy

Philip A. Tideman, Rosy Tirimacco, Andrew St. John, Gregory W. Roberts

Research output: Contribution to journal › Article › peer-review

47 Citations (Scopus)

23 Downloads (Pure)

Abstract

Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS₂ score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.

Original language	English
Pages (from-to)	44-48
Number of pages	5
Journal	Australian Prescriber
Volume	38
Issue number	2
DOIs	https://doi.org/10.18773/austprescr.2015.016
Publication status	Published - 1 Apr 2015
Externally published	Yes

Bibliographical note

Except where otherwise noted, all articles published in Australian Prescriber can be used under the CC BY-NC-ND licence.

Keywords

Anticoagulants
INR
Point-of-care services
Warfarin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18773/austprescr.2015.016Licence: CC BY-NC-ND

Tirimacco_How_P2015Final published version, 294 KBLicence: CC BY-NC-ND

Cite this

@article{8f3219179e00457ca1a5866d08e12fe1,

title = "How to manage warfarin therapy",

abstract = "Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS2 score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.",

keywords = "Anticoagulants, INR, Point-of-care services, Warfarin",

author = "Tideman, {Philip A.} and Rosy Tirimacco and {St. John}, Andrew and Roberts, {Gregory W.}",

note = "Except where otherwise noted, all articles published in Australian Prescriber can be used under the CC BY-NC-ND licence.",

year = "2015",

month = apr,

day = "1",

doi = "10.18773/austprescr.2015.016",

language = "English",

volume = "38",

pages = "44--48",

journal = "Australian Prescriber",

issn = "0312-8008",

publisher = "Commonwealth of Australia",

number = "2",

}

TY - JOUR

T1 - How to manage warfarin therapy

AU - Tideman, Philip A.

AU - Tirimacco, Rosy

AU - St. John, Andrew

AU - Roberts, Gregory W.

N1 - Except where otherwise noted, all articles published in Australian Prescriber can be used under the CC BY-NC-ND licence.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS2 score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.

AB - Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS2 score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.

KW - Anticoagulants

KW - INR

KW - Point-of-care services

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=84926303105&partnerID=8YFLogxK

UR - https://www.nps.org.au/australian-prescriber/articles/how-to-manage-warfarin-therapy

U2 - 10.18773/austprescr.2015.016

DO - 10.18773/austprescr.2015.016

M3 - Article

AN - SCOPUS:84926303105

SN - 0312-8008

VL - 38

SP - 44

EP - 48

JO - Australian Prescriber

JF - Australian Prescriber

IS - 2

ER -

How to manage warfarin therapy

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this